STOCK TITAN

Lazard, Inc. Form 4 Filings

LAZ NYSE

Every Form 4 that Lazard, Inc. (LAZ) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow LAZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LAZ filings page.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported that CEO & Chairman Peter Richard Orszag executed a series of equity transactions involving Common Stock and derivative awards. On August 24, 2026, he exercised 250,000 Stock Price Profits Interest Participation Rights (SP-PIPRs), receiving 250,000 shares of Common Stock, and disposed of 75,000 shares back to the company to cover estimated taxes from that exchange. On August 25, 2026, he sold 125,000 shares of Common Stock at a weighted average price of $43.5203 per share under a Rule 10b5-1 trading plan adopted on March 13, 2025, with sales intended to cover estimated taxes and other personal expenditures. Following the derivative exercise, 1,000,000 SP-PIPRs remain outstanding, including 500,000 scheduled to vest on or around August 23, 2028, and 500,000 scheduled to vest on or around August 23, 2030, subject to continued service and, for the latter, a stock price milestone.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported that director Stephen R. Howe Jr., as the reporting person, received a grant of 103 Deferred Stock Units (DSUs) under Lazard, Inc.'s 2018 Incentive Compensation Plan. These DSUs, elected in lieu of cash director compensation, will convert into an equal number of shares of Common Stock on a one-for-one basis when he ceases to serve on the Board, bringing his directly held DSU balance to 14,843 units.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported that Chief Accounting Officer Michael Gathy received an award of 145 Restricted Stock Units (RSUs), acquired through dividend equivalent reinvestment on existing RSU awards. Each RSU represents a contingent right to receive one share of Common Stock. Following this award, Gathy holds 13,037 RSUs, which will vest over time, and this figure excludes 1,438 shares of Common Stock that are directly or indirectly beneficially owned.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported that Christopher Hogbin, CEO of Asset Management, acquired 2,954 Restricted Stock Units (RSUs) linked to Lazard common stock. The RSUs arose from dividend equivalent reinvestment on existing RSU awards. Of these RSUs, 985 will vest on or around March 18, 2027, 985 on or around March 20, 2028, and 984 on or around March 22, 2029. Following this grant, Hogbin directly held 266,659 RSUs, which are separate from 11,829 shares of common stock that he also beneficially owns directly or indirectly.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported that Chief Operating Officer Alexandra Soto acquired 3,413 Restricted Stock Units (RSUs), treated as a grant or award tied to Lazard common stock. Each RSU represents a contingent right to receive one share of common stock if and when it vests.

The RSUs include amounts acquired through dividend equivalent reinvestment on existing RSU awards. Of this grant, 1,087 RSUs are scheduled to vest on or around March 1, 2027, 1,174 RSUs on or around March 1, 2028, and 1,152 RSUs on or around March 1, 2029. After this transaction, Soto directly holds 308,034 RSUs, excluding 148,185 shares of Lazard common stock that are directly or indirectly beneficially owned outside these RSUs.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported that Chief Financial Officer Tracy Farr acquired 426 Restricted Stock Units (RSUs) as a grant/award tied to dividend equivalent reinvestment. Each RSU represents a contingent right to receive one share of Common Stock. Of these RSUs, 233 vest on or around March 1, 2027, 146 vest on or around March 1, 2028, and 47 vest on or around March 1, 2029. Following this award, Farr holds 38,395 RSUs, excluding 2,889 shares of Common Stock separately beneficially owned.

Rhea-AI Summary

Lazard, Inc. granted an equity award to director Kathy Elsesser. She received 3,982 Deferred Stock Units (DSUs) at $0.00 per unit under Lazard, Inc.'s 2018 Incentive Compensation Plan as part of the Non-Executive Director Compensation arrangement. These DSUs convert into an equal number of common shares on a one-for-one basis after she leaves the Board, bringing her directly held DSU balance to 3,982.

Rhea-AI Summary

Lazard, Inc. director Ann-Kristin Achleitner received a grant of 3,777 Deferred Stock Units as part of the non-executive director compensation arrangement under the company’s 2018 Incentive Compensation Plan.

These DSUs will convert into an equal number of common shares after she leaves the Board, bringing her total deferred units to 27,036.

Rhea-AI Summary

Lazard, Inc. director Andrew M. Alper received a grant of 4,068 Deferred Stock Units (DSUs) at a price of $0.00 under the company’s 2018 Incentive Compensation Plan as part of non-executive director compensation. Each DSU will convert into one share of common stock when he leaves the board, bringing his total reported DSU holdings to 103,774.

Rhea-AI Summary

Lazard, Inc. director Peter Harrison received a grant of 3,777 Deferred Stock Units as part of the company’s Non-Executive Director compensation. Following this award, he holds 8,669 Deferred Stock Units in total. According to the plan, these units convert into common stock on a one-for-one basis when he leaves the board.

Rhea-AI Summary

Lazard, Inc. director Michelle Jarrard received a grant of 4,010 Deferred Stock Units as part of the company’s non-executive director compensation program. These units carry no cash exercise price and will convert into Common Stock on a one-for-one basis when she leaves the Board. Following this award, she directly holds 47,389 Deferred Stock Units tied to Lazard common shares.

Rhea-AI Summary

Lazard, Inc. director Iris Knobloch received a grant of Deferred Stock Units as part of her non-executive director compensation. She was awarded 4,010 Deferred Stock Units, bringing her reported holdings of these units to 42,160.

The Deferred Stock Units were granted under Lazard, Inc.'s 2018 Incentive Compensation Plan and will convert into an equal number of shares of common stock on a one-for-one basis after she resigns from, or otherwise ceases to be, a member of the Board of Directors.

Rhea-AI Summary

SCHULMAN DANIEL H reported acquisition or exercise transactions in this Form 4 filing.

Lazard, Inc. director Daniel H. Schulman received 4,358 Deferred Stock Units (DSUs) as a compensation award. The DSUs were granted under Lazard’s 2018 Incentive Compensation Plan as part of the non-executive director compensation. Following this grant, he holds 15,037 DSUs, each convertible into one share of common stock after he leaves the board.

Rhea-AI Summary

Lazard, Inc. director Dmitry Shevelenko received 3,777 Deferred Stock Units (DSUs) as a grant under the company’s 2018 Incentive Compensation Plan. These DSUs were awarded as part of the non-executive director compensation arrangement and carry no cash exercise price.

Each DSU will convert into one share of Lazard common stock after Shevelenko resigns from, or otherwise ceases to be, a member of the Board of Directors. Following this award, he now holds a total of 5,903 DSUs, all representing future rights to common shares rather than an immediate stock purchase or sale.

Rhea-AI Summary

Lazard, Inc. director Stephen R. Howe Jr. received a grant of 4,242 Deferred Stock Units as compensation under the company’s 2018 Incentive Compensation Plan for non-executive directors. Following this award, he holds a total of 14,740 Deferred Stock Units directly.

The Deferred Stock Units are tied to Lazard common stock on a one-for-one basis. They will be converted into shares of common stock after Howe resigns from, or otherwise ceases to be, a member of Lazard’s Board of Directors, making this a deferred, equity-based compensation arrangement rather than an open-market stock transaction.

Rhea-AI Summary

Lazard, Inc. Chief Financial Officer Tracy Farr received a grant of 393 Restricted Stock Units (RSUs) on Common Stock. These RSUs were acquired under dividend equivalent reinvestment provisions tied to existing RSU awards, so this is a compensation-related award rather than an open-market share purchase.

Following this award, Farr holds 37,969 RSUs, each representing a contingent right to one share of Common Stock. Of the RSUs in this position, 214 are scheduled to vest on or around March 1, 2027, 135 on or around March 1, 2028, and 44 on or around March 1, 2029.

Rhea-AI Summary

Lazard, Inc. Chief Accounting Officer Michael Gathy received a grant of 134 Restricted Stock Units (RSUs) on May 22, 2026, recorded as a grant/award acquisition. These RSUs were added through dividend equivalent reinvestment on existing RSU awards.

Each RSU represents a contingent right to receive one share of Lazard common stock. Following this grant, Gathy holds 12,892 RSUs, with 62 scheduled to vest on or around March 1, 2027, 53 on or around March 1, 2028, and 19 on or around March 1, 2029. The reported RSU amount excludes 1,438 shares of common stock that he already beneficially owns directly or indirectly.

Rhea-AI Summary

Lazard, Inc. executive Christopher Hogbin, CEO of Asset Management, acquired 2,716 Restricted Stock Units (RSUs) at no cost through dividend equivalent reinvestment tied to existing RSU awards. Each RSU represents one share of common stock. After this grant, he holds 263,705 RSUs, excluding 11,829 common shares separately beneficially owned. Portions of the new RSUs are scheduled to vest in three tranches through 2029.

Rhea-AI Summary

Lazard, Inc. Chief Operating Officer Alexandra Soto received an award of 3,138 Restricted Stock Units (RSUs) on Common Stock. The filing classifies this as a grant or award acquisition, not an open-market purchase or sale, and each RSU represents a contingent right to one share of Common Stock.

The RSUs were acquired under dividend equivalent reinvestment provisions tied to existing RSU awards. Following this grant, Soto holds 304,621 RSUs directly, while a separate 148,185 shares of Common Stock are noted as directly or indirectly beneficially owned and are not part of this RSU award.

Of the newly reported RSUs, 1,000 are scheduled to vest on or around March 1, 2027, 1,079 on or around March 1, 2028, and 1,059 on or around March 1, 2029, providing a multi-year, stock-based compensation schedule.

Rhea-AI Summary

Lazard, Inc. director Andrew M. Alper received 857 Deferred Stock Units (DSUs) as a compensation grant. These DSUs were awarded on May 15, 2026 at a stated price of $0.00 per unit and increase his directly held DSU balance to 99,706 units. Under his annual election, these DSUs are received in lieu of cash fees and will convert into an equal number of Lazard common shares on a one-for-one basis after he leaves the board.

Rhea-AI Summary

Lazard, Inc. director Stephen R. Howe Jr. received a grant of 100 Deferred Stock Units as part of his non-executive director compensation. These units were elected in lieu of cash under Lazard’s 2018 Incentive Compensation Plan and convert into common stock on a one-for-one basis after he leaves the Board.

Following this grant, Howe holds 10,498 Deferred Stock Units directly. The transaction is a routine equity-based compensation award rather than an open-market purchase or sale.

Rhea-AI Summary

Lazard, Inc. executive Christopher Hogbin reported compensation-related equity activity and follow-on share sales. On vesting of prior Restricted Stock Unit (RSU) awards, he acquired 48,332 shares of Common Stock at no cost. The company withheld 24,674 shares to cover tax obligations tied to this vesting.

He then executed open-market sales of 7,885 shares at $40.37 on March 18 and 3,944 shares at $39.37 on March 19 under a pre-arranged Rule 10b5-1 trading plan intended to cover estimated taxes and personal expenditures. Following these transactions, he holds 11,829 Common shares directly and 260,989 RSUs, indicating he retains a substantial equity interest.

Rhea-AI Summary

Farr Tracy reported acquisition or exercise transactions in this Form 4 filing.

Lazard, Inc. Chief Financial Officer Tracy Farr received a grant of 12,982 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock. After this award, Farr holds 37,576 shares-equivalent RSUs directly.

The RSUs vest over three years, with 4,327 units scheduled to vest on or around March 1, 2027, another 4,327 on or around March 1, 2028, and 4,328 on or around March 1, 2029. This is a compensation-related equity award rather than an open-market stock purchase or sale.

Rhea-AI Summary

Lazard, Inc. CEO and Chairman Peter Richard Orszag reported a combination of equity awards and share sales. On March 16, 2026, he exercised 138,340 Restricted Participation Units, receiving the same number of Lazard common shares at a conversion price of $0.00 per unit.

To cover estimated taxes from this exchange, he disposed of 41,502 shares to the company at an average price of $40.82 per share. On March 17, 2026, he conducted open-market sales totaling 69,170 shares at weighted-average prices of $40.7318 and $41.6593 per share, executed under a pre-arranged Rule 10b5-1 trading plan intended to cover estimated taxes and personal expenditures. Following these transactions, he directly owns 210,942 shares of Lazard common stock.

Rhea-AI Summary

Soto Alexandra reported acquisition or exercise transactions in this Form 4 filing.

Lazard, Inc. Chief Operating Officer Alexandra Soto received a grant of 101,739 Restricted Stock Units, each representing a right to one share of common stock. These RSUs are scheduled to vest on or around March 1, 2029. Following this award, she holds 301,483 shares and units directly, underscoring that this filing reflects compensation rather than an open-market trade.

Rhea-AI Summary

Gathy Michael reported acquisition or exercise transactions in this Form 4 filing.

Lazard, Inc. reported that Chief Accounting Officer Michael Gathy received a grant of 5,564 Restricted Stock Units, each representing one share of common stock. This award increases his directly held RSUs to 12,758. Portions of the grant are scheduled to vest in March 2027, March 2028, and March 2029.

Rhea-AI Summary

Lazard, Inc. Chief Financial Officer Tracy Farr reported equity compensation activity tied to restricted stock units (RSUs). On March 2, 2026, 5,903 RSUs vested, resulting in the acquisition of 5,903 shares of common stock. The company withheld 3,014 shares at a price of $50.60 per share to cover taxes, leaving 2,889 common shares held directly. Following these transactions, Farr also directly holds 24,594 RSUs, each representing a contingent right to receive one share of common stock.

Rhea-AI Summary

Lazard, Inc. Chief Accounting Officer Michael Gathy reported routine equity award activity. On March 2, 2026, 2,251 Restricted Stock Units vested and converted into 2,251 shares of common stock, each RSU representing one share. The company then withheld 813 common shares, valued at $50.60 per share using the New York Stock Exchange closing price from the prior trading day, to cover taxes arising from the vesting, leaving Gathy with 1,438 common shares directly owned afterward.

Rhea-AI Summary

Lazard, Inc. Chief Operating Officer Alexandra Soto reported equity award activity involving Restricted Stock Units (RSUs) and Common Stock. On March 2, 2026, 64,743 RSUs were exercised into an equal number of shares of Common Stock at a price of $0.00 per share, reflecting vesting of prior RSU grants.

On the same date, 30,430 shares of Common Stock were withheld by the company at $50.60 per share to cover taxes arising from the RSU vesting, rather than sold in an open-market transaction. After these transactions, Soto directly beneficially owned 148,185 shares of Common Stock, including 113,872 shares previously directly or indirectly beneficially owned.

Rhea-AI Summary

Lazard, Inc. Chief Operating Officer Alexandra Soto acquired 2,553 Restricted Stock Units (RSUs) on February 20, 2026 as a grant and dividend-equivalent award. Each RSU represents a right to receive one share of common stock. After this transaction, she directly holds 264,487 RSUs. Of these, 625 are scheduled to vest on or around March 2, 2026, 927 on or around March 1, 2027, and 1,001 on or around March 1, 2028. The reported RSU amount excludes 113,872 shares of Lazard common stock that she directly or indirectly beneficially owns.

Rhea-AI Summary

Lazard, Inc. Chief Accounting Officer Michael Gathy reported an acquisition of 92 Restricted Stock Units on February 20, 2026 as a grant or award. Each RSU represents a contingent right to receive one share of common stock. Following this transaction, he directly holds 9,445 RSUs. Of these RSUs, 23 will vest on or around March 2, 2026, 38 on or around March 1, 2027, and 31 on or around March 1, 2028.

Rhea-AI Summary

Lazard, Inc. reported that Christopher Hogbin, its CEO of Asset Management, acquired 2,984 Restricted Stock Units (RSUs) as a grant or award. The RSUs were credited at no cash cost under dividend equivalent reinvestment provisions tied to existing RSU awards, increasing his directly held RSUs to 309,321.

Each RSU represents a contingent right to receive one share of common stock. Of the reported RSUs, 467 are scheduled to vest on or around March 16, 2026, 840 on or around March 18, 2027, 840 on or around March 20, 2028, and 837 on or around March 22, 2029.

Rhea-AI Summary

Lazard, Inc. Chief Financial Officer Tracy Farr reported an acquisition of 295 Restricted Stock Units (RSUs) on February 20, 2026, at a price of $0.00 per unit, pursuant to dividend equivalent reinvestment provisions on existing RSU awards.

Each RSU represents a contingent right to receive one share of Lazard common stock. After this transaction, Farr directly holds 30,497 RSUs. Of these RSUs, 58 are scheduled to vest on or around March 2, 2026, 155 on or around March 1, 2027, and 82 on or around March 1, 2028, subject to the underlying award terms.

Rhea-AI Summary

Lazard, Inc. director Stephen R. Howe Jr. acquired 83 Deferred Stock Units as a grant under the company’s 2018 Incentive Compensation Plan. He elected to receive these DSUs in lieu of all or part of his non-executive director cash compensation. After this award, he directly holds 10,398 Deferred Stock Units. The DSUs will convert into Lazard common stock on a one-for-one basis after he resigns from, or otherwise ceases to be a member of, the Board of Directors.

Rhea-AI Summary

Lazard, Inc. director Andrew M. Alper received 721 Deferred Stock Units (DSUs) as a grant under the company’s 2018 Incentive Compensation Plan. These units were elected in lieu of cash compensation and carry a zero dollar acquisition price. Following this award, Alper directly holds 98,849 DSUs, which will convert into an equal number of common shares after he leaves Lazard’s Board of Directors.

Rhea-AI Summary

Lazard, Inc. reported an equity award to a senior executive. On 12/04/2025, the company granted its Officer and CEO Asset Management, reported on this Form 4, 306,337 restricted stock units (RSUs), each representing a contingent right to receive one share of Lazard common stock.

According to the filing, of these RSUs, 47,865 are scheduled to vest on or around March 16, 2026, 86,158 on or around March 18, 2027, 86,157 on or around March 20, 2028, and another 86,157 on or around March 22, 2029. Following this grant, the executive beneficially owns 306,337 RSUs directly.

Rhea-AI Summary

Lazard, Inc. (LAZ) director Andrew M. Alper reported receiving 728 Deferred Stock Units (DSUs) on 11/17/2025 under the company’s 2018 Incentive Compensation Plan. These DSUs were elected in lieu of cash compensation under the non-executive director compensation arrangement. Following this grant, Alper beneficially owns 98,128 DSUs, held in direct form. Each DSU will convert into one share of Lazard common stock after he resigns from, or otherwise ceases to be, a member of the Board of Directors.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported that one of its directors elected to receive part of their board compensation in equity rather than cash. On 11/17/2025, the director acquired 83 Deferred Stock Units (DSUs) at a price of $0 under Lazard’s 2018 Incentive Compensation Plan, as amended, in lieu of cash compensation. Following this transaction, the director beneficially owns 10,315 derivative securities in the form of DSUs, held directly. Each DSU is designed to convert into one share of Lazard common stock after the director resigns from, or otherwise ceases to be a member of, the company’s Board of Directors.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported an insider equity grant for its Chief Operating Officer on a Form 4. On 11/14/2025, the officer acquired 2,622 Restricted Stock Units (RSUs) through the dividend equivalent reinvestment provisions of existing RSU awards. Each RSU represents a contingent right to receive one share of Lazard common stock.

After this transaction, the officer beneficially owned 261,934 RSUs. Of the newly reported RSUs, 642 are scheduled to vest on or around March 2, 2026, 952 on or around March 1, 2027, and 1,028 on or around March 1, 2028. The filing notes this amount excludes 113,872 shares of Lazard common stock directly or indirectly owned by the reporting person.

Rhea-AI Summary

Lazard, Inc. (LAZ) reported an insider equity award for its Chief Accounting Officer on a Form 4. On 11/14/2025, the officer acquired 95 Restricted Stock Units (RSUs) through dividend equivalent reinvestment tied to existing RSU awards. Each RSU represents a contingent right to receive one share of Lazard common stock. Following this transaction, the officer beneficially owns 9,353 derivative securities in the form of RSUs. Of these RSUs, 23 are scheduled to vest on or around March 2, 2026, 40 on or around March 1, 2027, and 32 on or around March 1, 2028.